Abbot Laboratories (Pakistan) Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, ABOT's sales rose 7% to Rs 20.3bn, from Rs 19.1bn, and profit after tax rose 13% to Rs 2.2bn, from Rs 1.9bn (compared with Apr–Jun 2025).
Earnings per share were Rs 22.47, against Rs 19.85 a year earlier.
At Rs 907.09, ABOT trades at 11.1 times earnings, with a dividend yield of 4.4%.
- P/E ratio
- 11.1
- Dividend yield
- 4.4%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 27%
- Net margin
- 11.0%
- trailing twelve months
- Debt to equity
- 0.01
ABOT quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 20.3bn | Rs 2.2bn | 10.8% | Rs 22.47 | — |
| Jan–Mar 2026 | Rs 17.7bn | Rs 1.9bn | 11.0% | Rs 19.82 | — |
| Oct–Dec 2025 | Rs 19.2bn | Rs 2.6bn | 13.6% | Rs 26.56 | Rs 40.00 |
| Jul–Sep 2025 | Rs 19.8bn | Rs 1.8bn | 9.2% | Rs 18.62 | — |
| Apr–Jun 2025 | Rs 19.1bn | Rs 1.9bn | 10.2% | Rs 19.85 | — |
| Jan–Mar 2025 | Rs 17.3bn | Rs 1.6bn | 9.2% | Rs 16.34 | — |
| Oct–Dec 2024 | Rs 18.6bn | Rs 1.3bn | 6.9% | Rs 13.12 | Rs 10.00 |
| Jul–Sep 2024 | Rs 17.4bn | Rs 1.8bn | 10.4% | Rs 18.48 | — |
ABOT annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Dec 2025 | Rs 75.4bn | Rs 8.0bn | Rs 81.37 | Rs 40.00 |
| Year to Dec 2024 | Rs 68.2bn | Rs 5.2bn | Rs 53.46 | Rs 10.00 |
| Year to Dec 2023 | Rs 55.5bn | Rs 262.0mn | Rs 2.67 | — |
| Year to Dec 2022 | Rs 49.3bn | Rs 3.0bn | Rs 30.69 | Rs 15.00 |
| Year to Dec 2021 | Rs 42.6bn | Rs 6.0bn | Rs 60.95 | Rs 40.00 |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 48.8bn
- Shareholders' equity
- Rs 32.1bn
- Cash & bank
- Rs 9.4bn
- Total debt
- Rs 450.0mn
- Current ratio
- 2.18
- 3-month high
- Rs 1019.35
- 3-month low
- Rs 871.15
- 1-month change
- -3.6%
- 3-month change
- -9.0%
Read more about ABOT
Other pharmaceuticals companies
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
ABOT: common questions
What is ABOT's share price?
Abbot Laboratories (Pakistan) Ltd (ABOT) last closed at Rs 907.09 on the Pakistan Stock Exchange.
Does ABOT pay a dividend?
Yes. Abbot Laboratories (Pakistan) Ltd paid Rs 40.00 per share for the year to Dec 2025, and the stock's dividend yield is 4.4%.
What were ABOT's latest results?
In the Apr–Jun 2026 quarter, ABOT's sales rose 7% to Rs 20.3bn, from Rs 19.1bn, and profit after tax rose 13% to Rs 2.2bn, from Rs 1.9bn (compared with Apr–Jun 2025).
What is ABOT's P/E ratio?
At Rs 907.09, ABOT trades at 11.1 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.